Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-649414
Filing Date
2016-07-15
Accepted
2016-07-15 16:22:06
Documents
9
Period of Report
2016-08-18
Effectiveness Date
2016-07-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d188736ddef14a.htm DEF 14A 886715
2 GRAPHIC g188736g12y68.jpg GRAPHIC 23045
3 GRAPHIC g188736g15l36.jpg GRAPHIC 35350
4 GRAPHIC g188736g79c78.jpg GRAPHIC 20118
5 GRAPHIC g188736image1.jpg GRAPHIC 77660
6 GRAPHIC g188736image2.jpg GRAPHIC 9183
7 GRAPHIC g188736image3.jpg GRAPHIC 3036
8 GRAPHIC g188736image4.jpg GRAPHIC 34351
9 GRAPHIC g188736image5.jpg GRAPHIC 7058
  Complete submission text file 0001193125-16-649414.txt   1171674
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 161769938
SIC: 2834 Pharmaceutical Preparations